News - Respiratory and Pulmonary, tiotropium


Popular Filters

New Ph III data show tiotropium Respimat effective across asthma severities


German family-owned drug major Boehringer Ingelheim has released new data from large scale, Phase III…

Boehringer IngelheimPharmaceuticalResearchRespimatRespiratory and Pulmonarytiotropium

Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma patients


German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III…

Boehringer IngelheimPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Boehringer reveals new data on olodaterol and tiotropium combo at ERS


German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

COPD market to grow to more than $13.4 billion in 2020


As a result of an expanding aging population, increases in drug treatment and the uptake of premium priced…

Boehringer IngelheimGlobalMarkets & MarketingolodaterolPharmaceuticalRespiratory and Pulmonarytiotropium

Back to top